---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-126650"
form_type: "8-K"
ticker: "NTRB"
cik: "0001676047"
company_name: "NutriBand Inc."
filed_at: "2025-12-30T23:59:59+00:00"
generated_at: "2026-05-16T11:59:57.443588+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nutriband sells 90% stake in Pocono Pharma for $5M to EarthVision Bio; retains 10%

## Summary
- Agreement to sell 90% interest in subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio.
- Nutriband shareholders will retain 10% stake in EarthVision Bio post-acquisition; closing expected Dec 31, 2025.
- Proceeds will fund continued development of AVERSA Fentanyl, an abuse-deterrent opioid patch.
- AVERSA Fentanyl has potential annual US sales estimate of $80M to $200M.

## SEC filing metadata
- accession: 0001213900-25-126650
- form_type: 8-K
- ticker: NTRB
- cik: 0001676047
- company_name: NutriBand Inc.
- filed_at: 2025-12-30T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676047/000121390025126650/0001213900-25-126650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676047/000121390025126650/ea0271298-8k_nutriband.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-126650
- JSON: https://secwatch.observer/filing/0001213900-25-126650.json
- Plain text: https://secwatch.observer/filing/0001213900-25-126650.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.